Caption Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-618
| Closed | -$42.3K | – | 1654 |
|
|
2024
Q2 | $42.3K | Sell |
618
-266,162
| -100% | -$18.5M | ﹤0.01% | 1062 |
|
|
2024
Q1 | $18.5M | Buy |
266,780
+226,783
| +567% | +$15.6M | 0.28% | 80 |
|
|
2023
Q4 | $2.86M | Buy |
+39,997
| New | +$2.3M | 0.04% | 510 |
|
|
2023
Q1 | – | Sell |
-12,205
| Closed | -$590K | – | 1652 |
|
|
2022
Q4 | $646K | Buy |
12,205
+5,500
| +82% | +$276K | 0.01% | 864 |
|
|
2022
Q3 | $312K | Buy |
+6,705
| New | +$350K | ﹤0.01% | 1175 |
|
|
2022
Q1 | – | Sell |
-17,144
| Closed | -$898K | – | 2048 |
|
|
2021
Q4 | $898K | Sell |
17,144
-26,235
| -60% | -$1.1M | 0.01% | 1084 |
|
|
2021
Q3 | $1.62M | Buy |
43,379
+33,319
| +331% | +$1.16M | 0.02% | 852 |
|
|
2021
Q2 | $411K | Buy |
10,060
+2,260
| +29% | +$83.5K | 0.01% | 1091 |
|
|
2021
Q1 | $265K | Sell |
7,800
-23,700
| -75% | -$822K | 0.01% | 888 |
|
|
2020
Q4 | $1M | Sell |
31,500
-28,173
| -47% | -$740K | 0.02% | 610 |
|
|
2020
Q3 | $1.53M | Buy |
59,673
+6,623
| +12% | +$151K | 0.04% | 513 |
|
|
2020
Q2 | $1.36M | Buy |
+53,050
| New | +$1.07M | 0.05% | 460 |
|
|
2019
Q2 | – | Sell |
-80,000
| Closed | -$1.03M | – | 860 |
|
|
2019
Q1 | $975K | Buy |
+80,000
| New | +$1.02M | 0.05% | 357 |
|
Other funds holding ITCI
KIM
HNB